Clopidogrel and proton pump inhibitors: can near patient testing help in the tailoring of dual antiplatelet prescription?

被引：2
|
作者：
Amoah, V.
Worrall, A. P.
Smallwood, A.
Armesilla, A. L. [2 ]
Nevill, A. M.
Cotton, J. M. [1 ]
机构：
[1] New Cross Hosp, Heart & Lung Ctr, Dept Cardiol, Wolverhampton WV10 OQP, W Midlands, England
[2] Wolverhampton Univ, Sch Appl Sci, Res Inst Healthcare Sci, Wolverhampton WV1 1DJ, W Midlands, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 06期
关键词：
OMEPRAZOLE; PHARMACOKINETICS; ASPIRIN;
D O I：
10.1111/j.1538-7836.2010.03855.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1422 / 1424
页数：3
相关论文
共 50 条
  • [41] Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar
    Awaisu, Ahmed
    Hamou, Fatima
    Mekideche, Lylia
    Muabby, Nisrine El
    Mahfouz, Ahmed
    Mohammed, Shaban
    Saad, Ahmad
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 353 - 361
  • [42] Does the dual platelet antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is recommended in all patients requiring dual platelet antiplatelet therapy
    Morini, Sergio
    Zullo, Angelo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (06) : 488 - 492
  • [43] Systematic Review: Observational Studies Assessing the Association Between Cardiovascular Outcomes and the Co-Prescription of Proton Pump Inhibitors With Clopidogrel
    Johansson, Saga
    Sweet, Stephen
    Nagy, PTer
    GASTROENTEROLOGY, 2013, 144 (05) : S217 - S217
  • [44] Meta-Analysis of Safety and Efficacy of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease
    Khan, Safi
    Asad, Zain
    Lone, Ahmad
    Rahman, Hammad
    Sattur, Sudhakar
    Kaluski, Edo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B325 - B325
  • [45] PROTON PUMP INHIBITORS DECREASE UPPER GASTROINTESTINAL BLEEDING IN HIGH-RISK PATIENTS ON DUAL ANTIPLATELET THERAPY
    Ruiz, Jose R.
    Moss, Steven F.
    D'Agata, Erika
    GASTROENTEROLOGY, 2018, 154 (06) : S701 - S701
  • [46] Proton pump inhibitors for prevention of bleeding episodes in cardiac patients with dual antiplatelet therapy - between Scylla and Charybdis?
    Trenk, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (01) : 1 - 10
  • [47] Meta-analysis of use of proton pump inhibitors with dual antiplatelet therapy after acute coronary syndrome
    Lone, A.
    Khan, S.
    Riaz, H.
    Riaz, I. B.
    Kaluski, E.
    EUROPEAN HEART JOURNAL, 2018, 39 : 678 - 678
  • [48] Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review
    Sherwood, Matthew W.
    Melloni, Chiara
    Jones, W. Schuyler
    Washam, Jeffrey B.
    Hasselblad, Vic
    Dolor, Rowena J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (11):
  • [49] Meta-Analysis of Efficacy and Safety of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease
    Khan, Safi U.
    Lone, Ahmad N.
    Asad, Zain Ul Abideen
    Rahman, Hammad
    Khan, Muhammad Shahzeb
    Saleem, Muhammad A.
    Arshad, Adeel
    Nawaz, Najma
    Sattur, Sudhakar
    Kaluski, Edo
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (12) : 1125 - 1133
  • [50] Influence of Proton Pump Inhibitors on the Antiplatelet Properties of Two Clopidogrel Dosing Regimens and the Role of CYP2C19 Genotype
    Harmsze, Ankie M.
    van Werkum, Jochem W.
    Deneer, Vera H. M.
    Ruven, Henk J.
    Klungel, Olaf H.
    Hackeng, Chris M.
    Ten Berg, Jurrien M.
    De Boer, Antonius
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S131 - S131
12345